Intraductal fulvestrant for therapy of ERα-positive ductal carcinoma in situ of the breast: a preclinical study
Guannan Wang(Arizona Department of Health Services), Saraswati Sukumar(Johns Hopkins University), Guangjun Nie(National Center for Nanoscience and Technology), Vered Stearns(Johns Hopkins University), Vanessa F. Merino(University of Maryland, Baltimore), Priya Pai(University of Nebraska Medical Center), Shengrong Sun(Wuhan University), Chuang Chen(Wuhan University), Suping Li(Jiaxing University), Jingping Yuan(Wuhan University), Preethi Korangath(Johns Hopkins University)
Cited by 20
Related Papers
The Genomic Landscapes of Human Breast and Colorectal Cancers
|Science|2007|2.8k
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k
CYP2D6 Genotype, Antidepressant Use, and Tamoxifen Metabolism During Adjuvant Breast Cancer Treatment
|JNCI Journal of the National Cancer Institute|2005|947
Active Tamoxifen Metabolite Plasma Concentrations After Coadministration of Tamoxifen and the Selective Serotonin Reuptake Inhibitor Paroxetine
|JNCI Journal of the National Cancer Institute|2003|850